BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15088894)

  • 1. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
    Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
    Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma.
    Yuasa T; Yoshiki T; Tanaka T; Kim CJ; Isono T; Okada Y
    Jpn J Cancer Res; 1998 Sep; 89(9):879-82. PubMed ID: 9818021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.
    Moll R; Wu XR; Lin JH; Sun TT
    Am J Pathol; 1995 Nov; 147(5):1383-97. PubMed ID: 7485401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.
    Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT
    Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uroplakin gene expression by normal and neoplastic human urothelium.
    Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
    Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma.
    Kageyama S; Yoshiki T; Isono T; Tanaka T; Kim CJ; Yuasa T; Okada Y
    Jpn J Cancer Res; 2002 May; 93(5):523-31. PubMed ID: 12036448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
    Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
    J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunocytochemical staining patterns of uroplakin observed on neoplastic and nonneoplastic tissue fragments obtained from upper urinary tract brush specimens.
    Xu X; Genega EM; Nasuti JF
    Acta Cytol; 2002; 46(4):684-9. PubMed ID: 12146031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
    Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
    J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of human uroplakin II gene from Chinese transitional cell carcinoma of bladder and construction of its eukaryotic expression vector.
    Chen F; Zeng F; Tong Q; Zheng L; Wang L; Dong J; Lu G
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):188-90, 211. PubMed ID: 16116969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
    Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF
    Int J Cancer; 2004 Oct; 111(6):934-9. PubMed ID: 15300806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
    Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
    Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity.
    Jiang S; Gitlin J; Deng FM; Liang FX; Lee A; Atala A; Bauer SB; Ehrlich GD; Feather SA; Goldberg JD; Goodship JA; Goodship TH; Hermanns M; Hu FZ; Jones KE; Malcolm S; Mendelsohn C; Preston RA; Retik AB; Schneck FX; Wright V; Ye XY; Woolf AS; Wu XR; Ostrer H; Shapiro E; Yu J; Sun TT
    Kidney Int; 2004 Jul; 66(1):10-9. PubMed ID: 15200408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens.
    Xu X; Sun TT; Gupta PK; Zhang P; Nasuti JF
    Cancer; 2001 Jun; 93(3):216-21. PubMed ID: 11391610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
    Zhang J; Ramesh N; Chen Y; Li Y; Dilley J; Working P; Yu DC
    Cancer Res; 2002 Jul; 62(13):3743-50. PubMed ID: 12097284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uroplakins as markers of urothelial differentiation.
    Sun TT; Liang FX; Wu XR
    Adv Exp Med Biol; 1999; 462():7-18; discussion 103-14. PubMed ID: 10599409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.